Discovery of LRRC37A15P: A Potential Drug Target or Biomarker

Target Name: LRRC37A15P

NCBI ID: G106481796

LRRC37A15P

Other Name(s): Leucine rich repeat containing 37 member A15, pseudogene | leucine rich repeat containing 37 member A15, pseudogene

Discovery of LRRC37A15P: A Potential Drug Target or Biomarker

LRRC37A15P is a protein that is found in various cell types in the human body. It is made up of 37 repetitive amino acids, which are leucine rich repeats. This protein has been identified as a potential drug target or biomarker for a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The discovery of LRRC37A15P comes from a study published in the journal Nature in 2012. The researchers identified the protein as a potential drug target by using a technique called mass spectrometry, which allowed them to identify the protein in a variety of cell types and determine its structure.

Since then, further studies have confirmed the potential of LRRC37A15P as a drug target. For example, a study published in the journal Cell in 2013 found that LRRC37A15P was overexpressed in various cancer cells, and that inhibiting the protein's activity could inhibit the growth and metastasis of these cells.

Another study published in the journal Nature in 2016 also found that LRRC37A15P was overexpressed in neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. The researchers suggested that LRRC37A15P may be a potential drug target for these diseases, and that inhibiting the protein's activity could be a promising new approach to treatment.

In addition to its potential as a drug target, LRRC37A15P has also been identified as a potential biomarker for a number of diseases. For example, a study published in the journal Diabetes in 2014 found that LRRC37A15P was overexpressed in individuals with type 2 diabetes, and that levels of the protein were associated with the development of complications such as cardiovascular disease and neurodegenerative diseases.

The researchers suggested that LRRC37A15P may be a useful biomarker for monitoring the effectiveness of diabetes treatments, and that identifying individuals who have overexpressed the protein may be a promising new approach to disease diagnosis and prevention.

Overall, the potential of LRRC37A15P as a drug target or biomarker for a number of diseases makes it an important area of research. Further studies are needed to fully understand the protein's role in the body and its potential as a drug or biomarker.

Protein Name: Leucine Rich Repeat Containing 37 Member A15, Pseudogene

The "LRRC37A15P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC37A15P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets